US Stock MarketDetailed Quotes

MIRA MIRA Pharmaceuticals

Watchlist

1.120
0.0000.00%

Close Dec 13 16:00 ET

1.150
+0.030+2.68%

Post 20:01 ET

18.55MMarket Cap-1.62P/E (TTM)

MIRA Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

-34.13%2.08M

78.38%1.73M

32.01%1.77M

20.97%8.53M

126.78%3.06M

74.75%3.16M

-59.92%970.22K

-8.96%1.34M

227.48%7.05M

1.35M

Selling and administrative expenses

-52.71%1.01M

4.20%1.12M

63.77%1.01M

117.22%6.5M

5,067.33%2.67M

191.39%2.14M

-32.65%1.07M

-0.49%614.24K

288.53%2.99M

--51.66K

-General and administrative expense

-52.71%1.01M

4.20%1.12M

63.77%1.01M

117.22%6.5M

5,067.33%2.67M

191.39%2.14M

-32.65%1.07M

-0.49%614.24K

288.53%2.99M

--51.66K

Research and development costs

5.14%1.07M

708.26%614.46K

180.66%762.28K

-33.11%1.57M

-56.25%387.12K

42.00%1.02M

-137.50%-101.02K

-43.30%271.61K

243.56%2.35M

--884.76K

Other operating expenses

----

-73.39%453.55K

--0

----

20.98%453.55K

144.32%1.7M

--411.3K

Operating profit

34.13%-2.08M

-78.38%-1.73M

-32.01%-1.77M

-20.97%-8.53M

-126.78%-3.06M

-74.75%-3.16M

59.92%-970.22K

8.96%-1.34M

-227.48%-7.05M

-1.35M

Net non-operating interest income expense

108.83%37.75K

113.31%39.4K

3,149.97%50.42K

-33,619.94%-3.46M

-154,544.45%-2.73M

-18,440.62%-427.73K

-12,681.30%-295.89K

57.20%-1.65K

57.95%-10.25K

-1.77K

Non-operating interest income

----

--39.4K

----

Non-operating interest expense

----

33,619.94%3.46M

----

12,681.30%295.89K

----

-57.95%10.25K

--1.77K

Total other finance cost

-108.83%-37.75K

----

-3,149.97%-50.42K

----

--427.73K

----

--1.65K

----

Other net income (expense)

Income before tax

43.03%-2.04M

-33.58%-1.69M

-28.09%-1.72M

-69.77%-11.98M

-328.86%-5.79M

-98.15%-3.59M

47.75%-1.27M

9.08%-1.34M

-224.29%-7.06M

-1.35M

Income tax

Net income

43.03%-2.04M

-33.58%-1.69M

-28.09%-1.72M

-69.77%-11.98M

-328.86%-5.79M

-98.15%-3.59M

47.75%-1.27M

9.08%-1.34M

-224.29%-7.06M

-1.35M

Net income continuous Operations

43.03%-2.04M

-33.58%-1.69M

-28.09%-1.72M

-69.77%-11.98M

-328.86%-5.79M

-98.15%-3.59M

47.75%-1.27M

9.08%-1.34M

-224.29%-7.06M

---1.35M

Minority interest income

Net income attributable to the parent company

43.03%-2.04M

-33.58%-1.69M

-28.09%-1.72M

-69.77%-11.98M

-328.86%-5.79M

-98.15%-3.59M

47.75%-1.27M

9.08%-1.34M

-224.29%-7.06M

-1.35M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

43.03%-2.04M

-33.58%-1.69M

-28.09%-1.72M

-69.77%-11.98M

-328.86%-5.79M

-98.15%-3.59M

47.75%-1.27M

9.08%-1.34M

-224.29%-7.06M

-1.35M

Basic earnings per share

46.15%-0.14

-28.11%-0.11

-20.00%-0.12

-60.95%-0.64

-415.03%-0.3915

-154.88%-0.26

37.09%-0.0859

0.04%-0.1

-169.38%-0.3976

-0.076

Diluted earnings per share

46.15%-0.14

-28.11%-0.11

-20.00%-0.12

-60.95%-0.64

-415.03%-0.3915

-154.88%-0.26

37.09%-0.0859

0.04%-0.1

-169.38%-0.3976

-0.076

Dividend per share

Currency Unit

USD

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	-34.13%2.08M	78.38%1.73M	32.01%1.77M	20.97%8.53M	126.78%3.06M	74.75%3.16M	-59.92%970.22K	-8.96%1.34M	227.48%7.05M	1.35M
Selling and administrative expenses	-52.71%1.01M	4.20%1.12M	63.77%1.01M	117.22%6.5M	5,067.33%2.67M	191.39%2.14M	-32.65%1.07M	-0.49%614.24K	288.53%2.99M	--51.66K
-General and administrative expense	-52.71%1.01M	4.20%1.12M	63.77%1.01M	117.22%6.5M	5,067.33%2.67M	191.39%2.14M	-32.65%1.07M	-0.49%614.24K	288.53%2.99M	--51.66K
Research and development costs	5.14%1.07M	708.26%614.46K	180.66%762.28K	-33.11%1.57M	-56.25%387.12K	42.00%1.02M	-137.50%-101.02K	-43.30%271.61K	243.56%2.35M	--884.76K
Other operating expenses	----	----	----	-73.39%453.55K	--0	----	----	20.98%453.55K	144.32%1.7M	--411.3K
Operating profit	34.13%-2.08M	-78.38%-1.73M	-32.01%-1.77M	-20.97%-8.53M	-126.78%-3.06M	-74.75%-3.16M	59.92%-970.22K	8.96%-1.34M	-227.48%-7.05M	-1.35M
Net non-operating interest income expense	108.83%37.75K	113.31%39.4K	3,149.97%50.42K	-33,619.94%-3.46M	-154,544.45%-2.73M	-18,440.62%-427.73K	-12,681.30%-295.89K	57.20%-1.65K	57.95%-10.25K	-1.77K
Non-operating interest income	----	--39.4K	----	----	----	----	----	----	----	----
Non-operating interest expense	----	----	----	33,619.94%3.46M	----	----	12,681.30%295.89K	----	-57.95%10.25K	--1.77K
Total other finance cost	-108.83%-37.75K	----	-3,149.97%-50.42K	----	----	--427.73K	----	--1.65K	----	----
Other net income (expense)
Income before tax	43.03%-2.04M	-33.58%-1.69M	-28.09%-1.72M	-69.77%-11.98M	-328.86%-5.79M	-98.15%-3.59M	47.75%-1.27M	9.08%-1.34M	-224.29%-7.06M	-1.35M
Income tax
Net income	43.03%-2.04M	-33.58%-1.69M	-28.09%-1.72M	-69.77%-11.98M	-328.86%-5.79M	-98.15%-3.59M	47.75%-1.27M	9.08%-1.34M	-224.29%-7.06M	-1.35M
Net income continuous Operations	43.03%-2.04M	-33.58%-1.69M	-28.09%-1.72M	-69.77%-11.98M	-328.86%-5.79M	-98.15%-3.59M	47.75%-1.27M	9.08%-1.34M	-224.29%-7.06M	---1.35M
Minority interest income
Net income attributable to the parent company	43.03%-2.04M	-33.58%-1.69M	-28.09%-1.72M	-69.77%-11.98M	-328.86%-5.79M	-98.15%-3.59M	47.75%-1.27M	9.08%-1.34M	-224.29%-7.06M	-1.35M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	43.03%-2.04M	-33.58%-1.69M	-28.09%-1.72M	-69.77%-11.98M	-328.86%-5.79M	-98.15%-3.59M	47.75%-1.27M	9.08%-1.34M	-224.29%-7.06M	-1.35M
Basic earnings per share	46.15%-0.14	-28.11%-0.11	-20.00%-0.12	-60.95%-0.64	-415.03%-0.3915	-154.88%-0.26	37.09%-0.0859	0.04%-0.1	-169.38%-0.3976	-0.076
Diluted earnings per share	46.15%-0.14	-28.11%-0.11	-20.00%-0.12	-60.95%-0.64	-415.03%-0.3915	-154.88%-0.26	37.09%-0.0859	0.04%-0.1	-169.38%-0.3976	-0.076
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Heat List

Overall

No Data